Fed. Circ. Upholds Shire's Victory In Generic Vyvanse Suit

The Federal Circuit on Thursday upheld a district court decision that several pharmaceutical companies infringed on Shire LLC's patent for the attention deficit hyperactivity disorder drug Vyvanse, but freed Johnson Matthey...

Already a subscriber? Click here to view full article